Mostly, their use is based on the synthetic lethality theory [2], i.e., to block the single-strand DNA break repair process in double-strand DNA break repair (BRCA1/2) deficient cancer cells that selectively eliminates the cancer cells via DNA damage accumulation while not affecting normal cells possessing intact double-strand DNA break repair system [3,4]. This evidence concerns the gene BRCA1 and cancer.